G. Frommeyer, Marco Schmidt, C. Clauss
Dec 1, 2012
Citations
3
Influential Citations
50
Citations
Journal
European Journal of Heart Failure
Abstract
Ranolazine (RAN) was reported to be effective and safe in converting atrial fibrillation (AF) to sinus rhythm by administration of a single dose (‘pill in the pocket’) to patients with structural heart disease. This study examines the underlying mechanisms for the antiarrhythmic benefit of RAN application in chronic heart failure (CHF).